Pei-Yi Chu Selected Research

cisplatin-DNA adduct

1/2022

Natural anthraquinone compound emodin as a novel inhibitor of aurora A kinase: A pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pei-Yi Chu Research Topics

Disease

85	Neoplasms (Cancer) 06/2022 - 02/2011
31	Breast Neoplasms (Breast Cancer) 06/2022 - 02/2011
18	Neoplasm Metastasis (Metastasis) 07/2021 - 12/2008
13	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 01/2010
12	Triple Negative Breast Neoplasms 01/2022 - 04/2012
11	Carcinogenesis 07/2021 - 07/2011
9	Inflammation (Inflammations) 07/2020 - 08/2012
6	Squamous Cell Carcinoma of Head and Neck 01/2021 - 02/2012
4	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 08/2012
4	Stomach Neoplasms (Stomach Cancer) 08/2021 - 08/2011
4	Lymphatic Metastasis 01/2021 - 02/2012
4	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2013
3	Ovarian Neoplasms (Ovarian Cancer) 02/2022 - 04/2021
3	Wounds and Injuries (Trauma) 01/2022 - 03/2006
3	Colonic Neoplasms (Colon Cancer) 01/2021 - 02/2017
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2016
3	Primitive Neuroectodermal Tumors (PNET) 01/2021 - 11/2017
3	Carcinoma (Carcinomatosis) 05/2020 - 10/2011
3	Osteoarthritis 03/2016 - 01/2015
3	Acute Kidney Injury (Acute Renal Failure) 01/2015 - 06/2011
3	Ulcer 01/2013 - 10/2008
2	Hypoxia (Hypoxemia) 06/2021 - 09/2020
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 07/2020
2	Liver Neoplasms (Liver Cancer) 12/2020 - 10/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 07/2019
2	Adenocarcinoma 11/2018 - 08/2012
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2017 - 11/2017
2	Fibrosis (Cirrhosis) 09/2017 - 01/2010

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2010
18	Biomarkers (Surrogate Marker)IBA 04/2022 - 06/2012
11	Pharmaceutical PreparationsIBA 09/2021 - 04/2012
9	Estrogen ReceptorsIBA 06/2022 - 02/2011
9	Sorafenib (BAY 43-9006)FDA Link 11/2017 - 01/2013
8	Phosphotransferases (Kinase)IBA 01/2022 - 02/2012
7	Biological ProductsIBA 01/2022 - 10/2011
7	Sesame Oil (Oil, Sesame)IBA 03/2016 - 07/2009
6	sesamolIBA 01/2015 - 03/2006
5	EnzymesIBA 06/2022 - 10/2011
5	Messenger RNA (mRNA)IBA 04/2022 - 07/2020
5	CateninsIBA 02/2022 - 01/2018
5	LigandsIBA 02/2022 - 04/2011
5	Indicators and Reagents (Reagents)IBA 04/2021 - 08/2012
5	ErbB Receptors (EGF Receptor)IBA 02/2016 - 04/2011
4	Therapeutic UsesIBA 02/2022 - 05/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2011
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2011
4	Progesterone Receptors (Progesterone Receptor)IBA 09/2020 - 11/2013
4	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2013
4	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 02/2019 - 01/2016
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2017 - 01/2014
4	CytokinesIBA 04/2015 - 12/2009
4	Interleukin-6 (Interleukin 6)IBA 04/2015 - 01/2013
4	NitritesIBA 01/2015 - 10/2008
3	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 01/2019
3	CalciumIBA 06/2022 - 10/2020
3	MicroRNAs (MicroRNA)IBA 04/2022 - 01/2016
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 12/2013
3	IronIBA 11/2021 - 05/2012
3	Hyaluronic Acid (Hyaluronan)IBA 08/2021 - 08/2018
3	Arecoline (Arecolin)IBA 01/2021 - 04/2011
3	InterleukinsIBA 09/2020 - 01/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020 - 01/2016
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019 - 11/2015
3	Hormones (Hormone)IBA 01/2017 - 04/2012
3	Phosphopyruvate Hydratase (Enolase)IBA 10/2015 - 10/2011
3	LipopolysaccharidesIBA 01/2015 - 12/2009
3	Superoxides (Superoxide)IBA 06/2011 - 03/2006
3	Hydroxyl RadicalIBA 06/2011 - 03/2006
2	PhosphoenolpyruvateIBA 06/2022 - 11/2017
2	Cyclin D1IBA 02/2022 - 01/2013
2	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 01/2022
2	Aurora Kinase AIBA 02/2022 - 01/2022
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 08/2021 - 08/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2021 - 08/2018
2	SolutionsIBA 08/2021 - 07/2019
2	P-SelectinIBA 08/2021 - 07/2019
2	fucoidanIBA 08/2021 - 07/2019
2	Phenobarbital (Luminal)FDA Link 01/2021 - 07/2009
2	KynurenineIBA 01/2021 - 04/2020
2	CarcinogensIBA 01/2021 - 04/2015
2	Vascular Endothelial Growth Factor CIBA 01/2021 - 08/2019
2	Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)IBA 01/2021 - 04/2020
2	OxidesIBA 01/2020 - 04/2011
2	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2019 - 08/2012
2	Leucine (L-Leucine)FDA Link 01/2019 - 01/2018
2	Tamoxifen FDA LinkGeneric 08/2018 - 09/2014
2	Oncogene Proteins (Oncogene Protein)IBA 08/2018 - 01/2017
2	Everolimus FDA Link 11/2017 - 11/2017
2	MTOR InhibitorsIBA 11/2017 - 11/2017
2	Tyrosine Kinase InhibitorsIBA 11/2017 - 02/2016
2	LipidsIBA 09/2017 - 04/2011
2	Docetaxel (Taxotere)FDA Link 09/2017 - 01/2017
2	Lapatinib (GW572016)FDA Link 02/2017 - 02/2016
2	Insulin (Novolin)FDA Link 02/2017 - 12/2013
2	ChromatinIBA 02/2017 - 08/2012

Therapy/Procedure

27	Therapeutics 04/2022 - 01/2014
4	Drug Therapy (Chemotherapy) 06/2021 - 01/2016
2	Precision Medicine 04/2022 - 01/2020
2	Immunotherapy 01/2021 - 07/2017
2	Neoadjuvant Therapy 01/2020 - 01/2016